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The field of DNA damage response has experienced an ex-
traordinary year in 2015. The Lasker Award in Basic Medi-
cal Research recognized Drs. Evelyn Witkin and Stephen J. 
Elledge for their groundbreaking works in the DNA damage 
response, followed by the Nobel Chemistry Prize honoring 
three pioneers in DNA damage repair. These highest awards 
in science attest to both the impact of DNA damage re-
search and the extraordinary accomplishments of their re-
cipients. The prototype concept of DNA damage response 
emerged from Evelyn Witkin’s study of UV-induced muta-
genesis in E. coli in the 1960s. Investigations on DNA 
damage responses in eukaryotes eventually made it plainly 
clear how vitally important these cellular mechanisms are in 
maintaining genetic stability of all living creatures and to 
human diseases. Here we briefly outline the milestones of 
DNA damage checkpoint research and the many contribu-
tions from Stephen Elledge, which led to his Lasker Award 
(Figure 1).   
INTRODUCTION  
The first discovery of cellular mechanisms countering the 
mutagenic effect of DNA damage actually preceded the 
discovery of DNA as the genetic material. In an elegantly 
told story (Friedberg, 1997), Errol Friedberg described how 
Albert Kelner stumbled upon photo-reactivation repair of 
 
Figure 1 (color online)  Stephen Elledge and his former trainees at the 
Lasker Award ceremony on September 18, 2015, New York. From left to 
right: Zheng Zhou (Professor, Baylor College of Medicine), Yolanda 
Sanchez (Associate Professor, Dartmouth College), Steve Elledge (HHMI, 
Harvard Medical School), and Lee Zou (Professor, Harvard Medical 
School, Massachusetts General Hospital). Photo credit: Stephen Elledge 
and the Lasker Foundation. 
UV lesions at the Cold Spring Harbor laboratory. In his 
1949 paper published in PNAS (Kelner, 1949), Albert Kel-
ner stated: 
“While it is premature to do more than to speculate on the mecha-
nism involved in light-induced recovery, the following is suggested as a 
working hypothesis. Much of the killing effect of ultraviolet-light is due 
to a light-labile alteration of some constituent in the cell. Exposure to 
visible light restores this altered constituent to its former state.” 
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The “constituent in the cell” would not be experimentally 
established as DNA until 1952 when Hershey and Chase 
presented the conclusion that DNA is the genetic material of 
the bacteriophage (Hershey and Chase, 1952).  
After DNA was identified as the genetic molecule, the 
field of DNA damage and mutagenesis has seen its infancy 
in the early 50s with the term “repair” first used by Salva-
dore Luria in 1952 (Friedberg, 1997). Over the past 6 dec-
ades, the DNA repair and mutagenesis field has evolved 
from enzymological study of individual DNA repair activi-
ties to the complex molecular network of DNA damage 
response; from the simple UV survival readout of bacterial 
and phage to cancer etiology and therapeutics. However, it 
is fair to say that much of what we know about DNA repair 
benefited in no small ways from early studies in E. coli and 
yeasts. The spectacular career of Stephen Elledge also fol-
lowed a similar path of organismal advance with contribu-
tions to the field that few, if any, could match. 
FROM E. coli TO HUMANS  
The DNA damage response consists of multiple lines of 
defense against genomic DNA damage, slowing cell cycle 
progression, modulating DNA repair activities, and utilizing 
lesion bypass mechanisms to cope with impediments to 
DNA replication. When Stephen Elledge began his graduate 
research at MIT with Graham Walker, he was drawn to the 
DNA damage tolerance and SOS response in E. coli. His 
work discovered the catalytic subunit of lesion bypass pol-
ymerase V (Elledge and Walker, 1983b), which led to the 
identification of its regulatory subunit UmuD and its dam-
age inducibility as part of the SOS response (Elledge and 
Walker, 1983a). His Ph.D thesis titled “Identification and 
characterization of genes involved in mutagenesis in Esche-
richia coli” has set the stage for his subsequent work on the 
DNA damage response. 
After earning his Ph.D degree in 1983, Steve joined Ron 
Davis laboratory at Stanford University as a Helen Hay 
Whitney fellow, combining his exceptional genetics skills 
and the increasingly powerful budding yeast system. He had 
a clear objective to begin his postdoc work with —to clone 
the yeast RecA homolog, so that the eukaryotic counterpart 
of the SOS pathway would be unraveled. As he recounted 
recently (Elledge, 2015), an in situ screen of a yeast ge-
nomic DNA expression library using E. coli RecA antibod-
ies fortuitously identified the small subunit of ribonuclease 
reductase (RNR2) gene. Even though RNR expression is 
highly induced upon DNA damage (Elledge and Davis, 
1989), the cis-element mediating the inducibility does not 
resemble that of the E. coli lexA gene. His work, however, 
defined a new mode of regulating DNA damage response 
genes in eukaryotic cells.  
In 1989, Steve was recruited to the faculty of Baylor 
College of Medicine, where he continued to study the regu-
latory mechanism controlling RNR expression in response 
to DNA damage. In a yeast genetic screen for mutants una-
ble to induce RNR genes, the protein kinase DUN1 has 
emerged as a key regulator of the DNA damage response. 
This was a first piece of evidence showing that a protein 
kinase reacts to DNA damage, revealing the signal trans-
duction pathway governing the DNA damage response 
(Zhou and Elledge, 1993). Subsequent studies by the 
Elledge lab has identified the key proteins that mediate 
damage signaling, revealing a kinase cascade comprised of 
Mec1, Rad53, and Dun1, and many of their regulators and 
effectors. By this time, the concept of cell cycle checkpoint 
had been proposed to explain the delay of cell cycle pro-
gression upon DNA damage. Nonetheless, how cells enact 
such control over the complex cell cycle machinery was by 
no means perspicacious. In a seminal review in Science, 
“Cell cycle checkpoints: preventing an identity crisis”, Ste-
ve formulated his visions of the biochemical nature, signal-
ing mechanisms, and effector engagement of the cell cycle 
checkpoint (Elledge, 1996). His visions have played a major 
role in placing the concept of checkpoint in many different 
biological contexts, greatly enhancing the appreciation of 
this cellular process. His predictions turned out to be both 
visionary and accurate. The main framework of the check-
point has been proven to be the signal transduction cascade 
he had envisaged, mediated by protein post-translational 
modifications through phosphorylation and subsequently 
expanding to many other forms such as ubiquitination and 
sumoylation. 
While his laboratory was busy delineating the DNA 
damage checkpoint pathways in yeast, Steve began to shift 
his attention to the DNA damage response in mammalian 
cells. The yeast model that he built has paved a solid path to 
the identification of many mammalian DNA checkpoint 
proteins, such as CHK1 and CHK2 (Sanchez et al., 1996; 
Sanchez et al., 1997). As more and more mammalian 
checkpoint proteins emerged, the key question regarding 
checkpoint activation remained —How does the checkpoint 
recognize the presence of DNA damage and activate the 
signaling cascade? Given that DNA damages vary tremen-
dously in chemical and structural forms, it is unlikely that a 
few checkpoint sensing factors are able to recognize all 
forms of DNA lesions. This fundamental question was an-
swered when the DNA damage-induced binding of RPA, 
the predominant single-stranded DNA (ssDNA) binding 
protein in human cells, and ATRIP, the regulatory partner 
of the checkpoint initiating kinase ATR, was identified (Zou 
and Elledge, 2003). By exposing ssDNA, both DNA dam-
age repair intermediates and replication fork stress can trig-
ger checkpoint activation. This paradigm of DNA damage 
sensing through ssDNA, conserved in both yeast and hu-
mans, has revealed a remarkable similarity between the 
checkpoint response in eukaryotes and the SOS response in 
bacteria. Steve’s work on DNA damage responses from E. 
coli to humans has completed a full circle.    
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BEYOND THE CHECKPOINT 
In addition to his groundbreaking work on the DNA damage 
response, Steve has made many seminal contributions to 
other research areas. For many years, Steve has been a pio-
neer in the cell cycle field. He was one of the first to identi-
fy the CDK inhibitor p21. He has also played a critical role 
in the discovery of cullin family ubiquitin ligases. In recent 
years, Steve has been a leader in combined genomic and 
genetic studies using human cells, making major discoveries 
in the DNA damage response, protein degradation, cancer 
therapy, and HIV infection. Steve’s achievements are al-
ways accompanied by his exceptional aptitude in technolo-
gy development. Even as a graduate student, he was already 
significantly accomplished in devising molecular genet-
ics-based functional screens. The λACT cDNA library he 
designed allowed the yeast two-hybrid system to be de-
ployed as a common protein-protein interaction screening 
and testing tool in every laboratory (Durfee et al., 1993). As 
soon as the RNA interference technology emerged, Steve 
was among the few leaders who constantly revamped the 
design and efficiency of this powerful platform. He has 
provided the field with many crucial resources including the 
atlas of ubiquitinated proteins and ATM/ATR substrates. 
More recently, his lab invented a viral infection profiling 
method that detects a person’s “virome” with a minute 
amount of blood sample (Xu et al., 2015). The many con-
ceptual and practical innovations in technology advance-
ment broadened his research impact far beyond the genomic 
instability field. 
The field of DNA damage response has experienced tre-
mendous growth. Its impact on cancer etiology and cancer 
therapy is becoming increasingly clear. The ever-growing 
knowledge from the DNA damage field has enabled us to 
better understand how cancer cells evolve, and also to target 
them based on their intrinsic DNA damage response defi-
ciencies. Direct and indirect DNA-targeting therapies, from 
proton particle radiation therapy to the ever-improving 
platinum drugs, may be applied with more efficacies based 
on the DNA damage response of the tumor. Mechanistic 
delineation of the DNA damage response also guides the 
creation of drugs already in clinics, such as PARP inhibi-
tors, or in clinical trials, such as the ATR, CHK1 and WEE1 
inhibitors. These advances in improving human health attest 
to the impactful research of the DNA damage response col-
lectively, and the extraordinary accomplishments of Ste-
phen Elledge who, with Evelyn Witkin, is the most deserv-
ing recipient of the 2015 Albert Lasker award for Basic 
Medical Research.  
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